In a significant leap forward for digital healthcare, Vancouver-based Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) has proudly announced its receipt of funding from The National Institute of Health (NIH) to develop an innovative, culturally sensitive artificial intelligence (AI) approach to collecting family medical histories. This pioneering project, in partnership with Rush River Research in Minneapolis, is set to revolutionize how medical information is gathered, particularly for African-American families.
Bridging the Gap in Medical Data Collection
The conventional methods clinicians use to collect family medical histories often fall short when it comes to adequately capturing crucial information from blended families or non-traditional relationships, which are prevalent in racial or ethnic minority communities. This shortfall is even more pronounced in African-American communities, where historical trauma and systemic bias may limit the available information about relatives' health. Treatment.com's initiative aims to address these disparities head-on, using AI to refine and improve the way health data is collected and recorded.
A Culturally Sensitive Approach
Recognizing the unique challenges faced by African-American families, Treatment.com and Rush River Research have engaged directly with the community, organizing multiple focus groups with African American doctors and community members. These discussions have been instrumental in developing and prototyping culturally sensitive methods to collect family health information, ensuring that the AI platform can accommodate the nuances of diverse family structures and histories.
Towards a Fairer Future in Healthcare
As part of its commitment to reducing health inequity, Treatment.com is also focused on building the world's most comprehensive and integrated online medical library powered by AI — the Global Library of Medicine. This ambitious project aims to ensure that future diagnostic and treatment information provided by AI platforms is free from the biases currently reflected in medical AI programs. By involving African-American voices in the evaluation and improvement of the Treatment platform, the company is ensuring that a broad and diverse perspective informs the continuous enhancement of its technology.
From Prototype to Commercial Solution
The initial prototype for the family history solution has been seamlessly integrated into the Treatment AI platform. With ongoing enhancements, this solution will be rigorously tested and implemented in future iterations of the Global Library of Medicine platform. Following this successful development phase, Treatment and Rush River Research have submitted an expanded Phase 2 grant proposal to the NIH. The aim is to evolve the prototype into a commercial solution that can be widely adopted and integrated into electronic health records and online applications.
A Visionary Statement
Kevin Peterson MD, MPH, FRCS(Ed), FAAFP, Chief Medical Officer at Treatment.com, encapsulates the vision of the project: "Old data approaches inevitably reflect old biases. Treatment confronts issues of historical bias by reinventing how data about families is collected and stored to reflect the realities of modern life."
A Call to Investors and Traders
For investors and traders in the healthcare and technology sectors, Treatment.com's innovative approach represents not just a leap in healthcare equity but also a potentially promising investment opportunity. By addressing long-standing disparities and biases, Treatment.com is not only advancing the field of digital health but also positioning itself as a leader in the rapidly growing market for AI-driven healthcare solutions. As the project moves from prototype to commercialization, the potential for significant impact — both socially and financially — is immense.
In conclusion, Treatment.com's (CSE: TRUE) culturally sensitive AI initiative for collecting family medical histories is a beacon of innovation in the healthcare sector, promising a future where medical data collection is inclusive, accurate, and reflective of our diverse societies. For traders and investors, this represents a unique opportunity to be part of a venture that is set to redefine the standards of healthcare and medical data analysis in the digital age.
Some of the other Health Care AI related stocks to keep an eye on include NVIDIA Corp (NASDAQ: NVDA), SoundHound AI Inc (NASDAQ: SOUN), Symbotic Inc (NASDAQ: SYM), Upstart Holdings Inc (NASDAQ: UPST), Procept BioRobotics Corp (NASDAQ: PRCT), AeroVironment Inc. (NASDAQ: AVAV), Intuitive Surgical Inc (NASDAQ: ISRG).
Disclaimer: This news article is for information purposes only and is neither a solicitation or recommendation to buy nor an offer to sell securities. The Bull Report is not-a-registered-investment-advisor. The Bull Report is not a broker-dealer. Information, opinions, and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. The Bull Report accepts no liability for any losses arising from an investor’s reliance on the use of this material. Starting on Mar 15, 2024 The Bull Report has been compensated $47,000 per month for coverage of TRUE by Sunburst Capital Corp. The Bull Report and its affiliates or officers may purchase, hold, and sell shares of common stock of this stock, in the open market at any time without notice. The Bull Report will not update its purchases and sales of this stock in any future postings on The Bull Report’s websites. Certain information included herein is forward-looking within the context of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. The words “may”, “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend,” ” project,” and similar expressions and variations thereof are intended to identify forward-looking statements. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. *The Bull Report does not set price targets on securities. Never invest in a stock discussed on this website or in this email alert unless you can afford to lose your entire investment.
Sources:
https://www.thebullreport.com/true/
https://finance.yahoo.com/quote/TRUE.CN/
https://finance.yahoo.com/news/treatment-ai-passes-medical-school-123000812.html
Media Contact
Company Name: TheBullReport
Contact Person: Jason Roy
Email: info@thebullreport.com
City: Dallas
State: Texas
Country: United States
Website: https://www.thebullreport.com/
